Otros idiomas Arecor Therapeutics plc

Acciones

AREC

GB00BMWLM973

Mercado cerrado - London S.E. Otros sitios de cotización 17:35:05 26/04/2024			Varia. Cinco días.	Varia. 1 de enero.
136,5 ^GBX	0,00 %		+6,23 %	-25,21 %

23/04	El director financiero de Arecor dejará la empresa en julio tras cinco años	AN
23/04	Arecor Therapeutics plc anuncia el cese de Susan Lowther como Secretaria de la Empresa y como Directora del Consejo, con efecto a partir del 22 de julio de 2024	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Arecor chief financial officer to leave in July after five years	23/04
Arecor Therapeutics CFO to Leave in July	23/04
Arecor Therapeutics plc Announces Stepping Down of Susan Lowther as Chief Financial Officer, Effective from July 22, 2024	23/04
Arecor Therapeutics plc Announces Stepping Down of Susan Lowther as Company Secretary and as A Board Director, Effective from July 22,2024	23/04
Arecor Therapeutics announces collaboration on oral GLP-1 drug for diabetes and obesity treatment	14/03
Arecor to develop "holy grail" diabetes treatment with partner TRx	12/03
ARECOR AND TRx BIOSCIENCES ESTABLISH RESEARCH COLLABORATION TO DEVELOP ORAL GLP-1 WITH ENHANCED BIOAVAILABILITY	12/03
Arecor Therapeutics plc and Trx Biosciences Limited Announces Research Collaboration for the Formulation Development of an Oral GLP-1 Receptor Agonist Product	12/03
EARNINGS AND TRADING: East Star, Getech strike Kazakhstan JV	29/02
Arecor Therapeutics hails Arestat as 2023 performance "strong"	01/02
Arecor pleased as investee Inhibrx sells therapy to Sanofi	23/01
Patent boosts for DG Innovate and Arecor Therapeutics	18/01
Arecor Therapeutics Gains European Patent for Insulin Product Formulations	18/01
Arecor expands speciality hospital collaboration with partner	08/01
Arecor Therapeutics Expands Formulation Study Collaboration with Pharmaceutical Partner	08/01
Arecor Therapeutics plc Expands Ongoing, Exclusive Formulation Study Collaboration with the Pharmaceutical Division of One of the World's Largest Chemicals Marketing and Pharmaceuticals Companies	08/01
Arecor Therapeutics reveals deal with "global medical products company"	05/12
Arecor inks co-development deal with global medical company	04/12
Arecor Therapeutics Signs Exclusive License Option Agreement for Oncology Product	04/12
Arecor Therapeutics plc Announces Co-Development and Exclusive Licence Option Agreement	04/12

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Arecor Therapeutics plc

Acciones

AREC

GB00BMWLM973

Otros idiomas

Filtros